Liver Fibrosis Current Events | Liver Fibrosis News | 6
|
| Page
6 of
34 |
668 Results |
|
|
|
Sort By:
Page Views | Date |
Women given liver transplants outlive male recipients by around 4 years
Female liver transplant recipients outlive men given the same procedure by an average of 4.5 years, suggests research published ahead of print in Gut. view more (2006-09-28)
Doubling of deaths from liver cancer in 30 years
Deaths from liver cancer have almost doubled in the past 30 years, shows research in Gut. A relatively rare type of liver cancer arising from the bile ducts - intrahepatic cholangiocarcinoma - accounts for virtually all of the increase. The research team analysed deaths coded by liver tumour between 1968 and 1998, using national statistics for... view more... (2001-05-16)
Do patients at risk for B-cell malignancy need antiviral treatment?
Some studies have shown that a relationship of hepatitis C (HCV) infection with type II mixed cryoglobulinemia exists. However the precise mechanism remains unclear. view more (2009-04-15)
High circulating D-dimers are associated with presence of ascites
The liver is the production site of most of the proteins which favour and inhibit the process of coagulation and fibrinolysis. view more (2008-04-30)
Most chronic hepatitis C sufferers will develop cirrhosis in later life
Nearly 80 percent of chronic hepatitis C sufferers who have the disease for several decades will develop cirrhosis or end-stage liver disease later in life. view more (2005-09-01)
UCSD researchers identify critical receptor in liver regeneration
In studies in mouse models, researchers at the University of California, San Diego (UCSD) School of Medicine have found that a cellular receptor involved in triggering cell death is also a necessary component of tissue repair and regeneration immediately following liver injury. view more (2007-03-30)
Common cold virus efficiently delivers corrected gene to cystic fibrosis cells
Scientists have worked for 20 years to perfect gene therapy for the treatment of cystic fibrosis, which causes the body to produce dehydrated, thicker-than-normal mucus that clogs the lungs and leads to life threatening infections. view more (2009-07-21)
Viagra for alleviation of pulmonary hypertension?
Results of a preliminary study in this week's issue of THE LANCET suggest that Viagra may have a future role in the treatment of pulmonary hypertension (increased blood pressure in the pulmonary artery), a severe and potentially fatal condition causing respiratory impairment. Lung fibrosis (scarring of the lungs due to inflammation of the... view more... (2002-09-18)
Even at High Doses, Gadolinium-Based Contrast Agents Cannot by Themselves Cause Patients to Develop Nephrogenic Systemic Fibrosis
Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems. view more (2009-07-01)
Helping Cystic Fibrosis Patients Beat Bugs
People with weakened immune systems, including patients with cystic fibrosis, could be better protected in future from a highly resilient bacteria thanks to work by medical scientists from the University of Leeds. The research is presented today, Wednesday 10 September 2003, at the Society for General Microbiology's meeting at UMIST in Manchester.... view more... (2003-08-27)
Study links obesity to liver failure
Researchers have found that obesity can put patients with acute liver failure at increased risk of mortality and other major complications. view more (2006-05-25)
Mechanical engineering helps research into the liver
Artificial glass livers being developed at the University of Leeds could help those suffering from liver failure, and improve understanding of how the organ works, researchers believe. Dr Peter Walker of mechanical engineering is leading Leeds' contribution to a three-year £320,000 project that aims to replicate the geometry of the liver,... view more... (2004-01-26)
A new player in the battle against hepatitis prevents inflammation and the death of liver cells
Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have again achieved a breakthrough in research on hepatitis. view more (2005-09-02)
Varicella zoster infection causes severe autoimmune hepatitis
Autoimmune hepatitis (AIH) is a chronic liver inflammation of unknown etiology that is characterized by the presence of circulatory autoantibodies and ongoing liver tissue damage. view more (2009-03-03)
Using contrast enhanced sonography improves diagnosis of liver and spleen injuries
Contrast-enhanced sonography shows liver and spleen injuries better than non-contrast enhanced sonography. view more (2006-10-02)
New clinical guidelines for exacerbations in cystic fibrosis
The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices. view more (2009-10-23)
Skin care: new research into scar-free healing
New research from the University of Bristol shows that by suppressing one of the genes that normally switches on in wound cells, wounds can heal faster and reduce scarring. This has major implications not just for wound victims but also for people who suffer organ tissue damage through illness or abdominal surgery. view more (2008-01-21)
Researchers identify molecule that causes destructive lung inflammation in cystic fibrosis patients
Scientists at Children's Hospital of Pittsburgh of UPMC have identified a protein that is critical to the development of inflammation during lung infection in patients with cystic fibrosis (CF). view more (2006-11-07)
Medication effective for acute liver failure in early stages of disease
The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found. view more (2009-10-08)
Liver disease breakthrough by new University company
Ref: 03/49 14 April 2003 A new spin-out company from the University of Southampton aims to revolutionise the diagnosis and treatment of hepatitis C and save the NHS millions of pounds. HepCgen has been founded by liver disease specialist Dr William Rosenberg, who has worked and researched in this... view more... (2003-04-14)
|
|
| Page
6 of
34 |
668 Results |
|
|
|
Sort By:
Page Views | Date |
|
